Your browser doesn't support javascript.
Leveraging identity and access management technology to accelerate emergency COVID-19 vaccine delivery.
Gellert, George A.
  • Gellert GA; Imprivata Inc., 703 Sentry Hill, San Antonio, TX 78260, USA.
Ther Adv Vaccines Immunother ; 11: 25151355231173830, 2023.
Article in English | MEDLINE | ID: covidwho-20235902
ABSTRACT
COVID-19-related vaccine demand and delivery volume challenged delivery organizations as few crises have. Imperatives to ensure security of patient information, defend against cybersecurity threats, and accurately identify/authenticate clinician identity for patients remained unchanged. Deployment of identity access and management (IAM) and single sign-on (SSO) can accelerate operationalization of a vaccine delivery center when urgently needed in a crisis. Innovative application of existing IAM/SSO technology, combined with an identity governance solution, greatly accelerated vaccine delivery. Secure access enabled by IAM technology facilitated a rapid expansion (25 minutes) where 500 new vaccine delivery personnel were identified and authenticated during a period of high pandemic incidence. Existing digital identity solutions enabled a vaccine delivery organization to accelerate secure IAM of clinical staff during the peak of the COVID-19 pandemic. Existing IAM investments and capabilities that are widely implemented in nations with mature health information technology systems can greatly accelerate standing up emergent vaccine delivery capabilities and sites in the midst of a public health crisis.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Observational study / Prognostic study Topics: Vaccines Language: English Journal: Ther Adv Vaccines Immunother Year: 2023 Document Type: Article Affiliation country: 25151355231173830

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Observational study / Prognostic study Topics: Vaccines Language: English Journal: Ther Adv Vaccines Immunother Year: 2023 Document Type: Article Affiliation country: 25151355231173830